Literature DB >> 17267552

A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine.

Tzu-Kang Sang1, Hui-Yun Chang, George M Lawless, Anuradha Ratnaparkhi, Lisa Mee, Larry C Ackerson, Nigel T Maidment, David E Krantz, George R Jackson.   

Abstract

Mutations in human parkin have been identified in familial Parkinson's disease and in some sporadic cases. Here, we report that expression of mutant but not wild-type human parkin in Drosophila causes age-dependent, selective degeneration of dopaminergic (DA) neurons accompanied by a progressive motor impairment. Overexpression or knockdown of the Drosophila vesicular monoamine transporter, which regulates cytosolic DA homeostasis, partially rescues or exacerbates, respectively, the degenerative phenotypes caused by mutant human parkin. These results support a model in which the vulnerability of DA neurons to parkin-induced neurotoxicity results from the interaction of mutant parkin with cytoplasmic dopamine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17267552      PMCID: PMC6673194          DOI: 10.1523/JNEUROSCI.4810-06.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  54 in total

1.  The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons.

Authors:  Hakeem O Lawal; Hui-Yun Chang; Ashley N Terrell; Elizabeth S Brooks; Dianne Pulido; Anne F Simon; David E Krantz
Journal:  Neurobiol Dis       Date:  2010-05-26       Impact factor: 5.996

Review 2.  Modulation of the activity of dopaminergic neurons by SK channels: a potential target for the treatment of Parkinson's disease?

Authors:  Xiao-Kun Liu; Gang Wang; Sheng-Di Chen
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

3.  Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities.

Authors:  Cheng Wang; Ruifeng Lu; Xuezhi Ouyang; Michelle W L Ho; William Chia; Fengwei Yu; Kah-Leong Lim
Journal:  J Neurosci       Date:  2007-08-08       Impact factor: 6.167

Review 4.  Recent advances in using Drosophila to model neurodegenerative diseases.

Authors:  Bingwei Lu
Journal:  Apoptosis       Date:  2009-08       Impact factor: 4.677

5.  Developmental analysis of the dopamine-containing neurons of the Drosophila brain.

Authors:  Volker Hartenstein; Louie Cruz; Jennifer K Lovick; Ming Guo
Journal:  J Comp Neurol       Date:  2016-07-11       Impact factor: 3.215

6.  A tyrosine-based motif localizes a Drosophila vesicular transporter to synaptic vesicles in vivo.

Authors:  Anna Grygoruk; Hao Fei; Richard W Daniels; Bradley R Miller; Aaron Diantonio; David E Krantz
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 7.  RNA metabolism in the pathogenesis of Parkinson׳s disease.

Authors:  Bingwei Lu; Stephan Gehrke; Zhihao Wu
Journal:  Brain Res       Date:  2014-03-13       Impact factor: 3.252

8.  Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C. elegans.

Authors:  Sudipta Chakraborty; Pan Chen; Julia Bornhorst; Tanja Schwerdtle; Fabian Schumacher; Burkhard Kleuser; Aaron B Bowman; Michael Aschner
Journal:  Metallomics       Date:  2015-03-13       Impact factor: 4.526

Review 9.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

Review 10.  Drosophila melanogaster as a model organism of brain diseases.

Authors:  Astrid Jeibmann; Werner Paulus
Journal:  Int J Mol Sci       Date:  2009-02-02       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.